RxDoctor Payments Data

Brandi Basso, MD

Family Medicine · Livingston, LANPI 1154590842

Payments from drug & device makers

$948in general payments, 2019–2025

Across 58 payments — averaging $16.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$178
  • Novo Nordisk$173
  • Takeda Pharmaceuticals U.S.A., Inc.$113
  • Merck$99
  • AbbVie$67
  • Abbott$52
  • plus $266 from 12 others

What the payments were for

  • Food & beverage$948100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$948 in reported general payments places this provider in the 55th percentile of 1,469 family medicine providers in Louisiana.

See all family medicine providers in Louisiana

Medicare billing

Part B allowed, 2024
$13,991
Medicare patients
85
Services billed
196

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide164$189,347
OzempicSemaglutide84$95,338
JardianceEmpagliflozin93$89,134
TrulicityDulaglutide15$22,124
JanuviaSitagliptin Phosphate29$21,129
LinzessLinaclotide30$18,693
Synjardy XrEmpagliflozin/Metformin Hcl22$15,817
BelsomraSuvorexant14$5,975
Breo ElliptaFluticasone/Vilanterol12$5,061
DexilantDexlansoprazole13$3,772
SymbicortBudesonide/Formoterol Fumarate14$3,113
Gabapentin157$2,613
Nebivolol Hcl46$2,399
Metformin Er GastricMetformin Hcl11$2,221
Atorvastatin Calcium249$2,214

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$11$211,471179 claims
Novo NordiskOzempic$173$95,33884 claims
MerckJanuvia, Belsomra$99$27,10443 claims
AbbVieLinzess$67$18,69330 claims
GSKBreo Ellipta$178$5,06112 claims
Takeda Pharmaceuticals U.S.A., Inc.Dexilant$113$3,77213 claims
AstraZenecaSymbicort$24$3,11314 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 1,469 family medicine providers in Louisiana.

Other family medicine in Livingston

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →